Immunogenicity of a fusion protein linking the beta subunit carboxyl terminal peptide (CTP) of human chorionic gonadotropin to the B subunit of Esherichia coli heat-labile enterotoxin (LTB)

Vaccine

Volumn 14, Issue 16, 1996, Pages 1560-1568

  Rock, Edwin P ^a   Reich, Karl A ^a   Lyu, Dennis M ^a   Hovi, Marianne ^a   Hardy, Jonathan ^a   Schoolnik, Gary K ^a   Stocker, Bruce A D ^a   Stevens, Vernon ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ENTEROTOXIN; HYBRID PROTEIN; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL TOXINS; CHORIONIC GONADOTROPIN; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENETIC ENGINEERING; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; RABBITS; RECOMBINANT FUSION PROTEINS;

EID: 0030293169     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00046-1     Document Type: Article

References (46)

1. 1 Greasy, R.K. and Resnik, R. Maternal-Fetal Medicine, Harcourt, Brace, Jovanovich, New York, 1989
2. 2 Acevedo, H.F., Krichevsky, A., Campbell-Acevedo, E.A., Galyon, J.C., Buffo, M.J. and Hartsock, R.J. Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 1992, 69, 1829-1842
3. 3 Acevedo, H.F., Tong, J.Y. and Hartsock, R.J. Human chorionic gonadotropin beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 1995, 76, 1467-1475
4. 4 Canfield, R.E., Birken, S., Morse, J.H. and Morgan, F.J. Human chorionic gonadotropin. In: Peptide Hormones (Ed. Parsons, J.A.). University Park Press, Baltimore, 1976, pp. 299-315
5. 5 Talmadge, K., Vamvakopoulos, N.C. and Fiddes, J.C. Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone. Nature 1984, 307, 37-40
6. 6 Triozzi, P.L., Gochnour, D., Martin, E.W. et al. Clinical and immunologic effects of a synthetic β-human chorionic gonadotropin vaccine. Int. J. Oncol. 1995, 5, 1447-1453
7. 7 Hearn, J.P. Immunization against pregnancy. Proc. R. Soc., London 1976, 195, 149-153
8. 8 Talwar, G.P., Singh, O., Pal, R. et al. A vaccine that prevents pregancy in women. Proc. natn Acad. Sci. USA 1994, 91, 8532-8536
9. 9 Stevens, V.C. Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin. CIBA Found. Symp. 1986, 119, 200-225
10. 10 Jones, W.R., Bradley, J., Judd, S.J. et al. Phase I clinical trial of a World Health Organization birth control vaccine. The Lancet 1988, 8598, 1295-1298
11. 11 Talwar, G.P., Hingorani, V., Kumar, S. et al. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception 1990, 41, 301-316
12. 12 Blanco, J., Blanco, M., Garabal, J.I. and Gonzalez, E.A, Enterotoxins, colonization factors and serotypes of enterotoxigenic Escherichia coli from humans and animals. Microbiologica 1991, 7, 57-73
13. 13 Spangler, B.D. Structure and function of cholera toxin and the related Escherichi coli heat-labile enterotoxin. Microbiol. Rev. 1992, 56, 622-647
14. 14 Sixma, T.K., Pronk, S.E., Kalk, K.H. et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991, 351, 371-377
15. 15 Lebens, M. and Holmgren, J. Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier. Dev. biol. Stand. 1994, 82, 215-227
16. 16 Nashar, T.O., Amin, T., Marcello, A. and Hirst, T.R. Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 1993, 11, 235-240
17. 17 Clements, J.D. Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins. Infect. Immun. 1990, 58, 1159-1166
18. 18 Fiddes, J.C. and Goodman, H.M. The cDNA for the β-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough in the 3′-untranslated region. Nature 1980, 286, 684-687
19. 19 Maniatis, T., Fritsch, E.F. and Sambrook, J. Molecular Cloning. Cold Spring Harbor Press, Cold Spring Harbor, 1989
20. 20 Svennerholm, A.M. and Holmgren, J. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol. 1978, 1, 19-23
21. 21 Marcello, A., Loregian, A., Palu, G. and Hirst, T.R. Efficient extracellular production of hybrid E. coli heat-labile enterotoxin B subunits in a marine Vibrio. FEMS Microbiol. Lett. 1994, 117, 47-51
22. 22 Uesaka, Y., Otsuka, Y., Lin, Z. et al. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microbial Pathogenesis 1994, 16, 71-76
23. 23 Powell, J.E., Lee, A.C., Tregear, G.W., Niall, H.D. and Stevens, V.C. Characteristics of antibodies raised to carboxy-terminal peptides of hCG beta subunit. J. Reprod. Immun. 1980, 2, 1-13
24. 24 Wu, H.-Y. and Russell, M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 1993, 61, 314-322
25. 25 Dale, J.B. and Chiang, E.C. Intranasal immunization with recombinant Group A Streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J. infect. Dis. 1995, 171, 1038-1041
26. 26 Zhang, T. and Stanley, S.L. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SHEHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect. Immun. 1995, 63, 1349-1355
27. 27 Sixma, T.K., Pronk, S.E., Kalik, K.H., van Zanten, B.A.M., Berghuis, A.M. and Hol, W.G.J. Lactose binding to heat-labile enterotoxin revealed by x-ray crystallography. Nature 1992, 355, 561-564
28. 28 Sun, J.B., Holmgren, J. and Czerkinsky, C. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. natn Acad. Sci. USA 1994, 91, 10795-10799
29. 29 Lapthorn, A.J., Harris, D.C., Littlejohn, A. et al. Crystal structure of human chorionic gonadotropin. Nature 1994, 369, 455-461
30. 30 Wu, H., Lustbader, J.W., Liu, Y., Canfield, R.E. and Hendrickson, W.A. Structure of human chorionic gonadotropin at 2.6 angstrom resolution from MAD analysis of the selenomethionyl protein. Structure 1994, 2, 545-558
31. 31 Acevedo, H.F., Kellen, J.A., Wong, A.C., Gardner, H.A. and Szalai, J.P. Expression of human choriogonadotropin-like material correlates with metastatic phenotype of R3230 AC rat adenocarcinoma. Cancer Investigation 1987, 5, 177-185
32. 32 Yogeeswaran, G. and Salk, P. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 1981, 212, 1514-1516
33. 33 Kim, U. On the characteristics of tumor cells and host responses associated with metastatic potential. In 13th International Cancer Congress, Part C, Biology of Cancer. Alan R. Liss, Inc., New York, 1983, pp. 45-50
34. 34 Stevens, V.C. Birth control vaccines and immunological approaches to the therapy of noninfectious diseases. Infect. Dis. Clin. N. Am. 1990, 4, 343-354
35. 35 Talwar, G.P. Immuno-contraception. Curr. Opinion Immun. 1994, 6, 698-704
36. 36 Stevens, V.C., Powell, J.E., Lee, A.C. and Griffin, P.D. Anti-fertility effects from immunization of female baboons with C-terminal peptides of human chorionic gonadotropin. Fertil. Steril. 1981, 36, 98-105
37. 37 Dirnhofer, S., Klieber, R., De Leeuw, R. et al. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine. FASEB J. 1993, 7, 1381-1385
38. 38 Singh, O., Rao, L.V., Gaur, A., Sharma, N.C., Alam, A. and Talwar, G.P. Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil. Steril. 1989, 52, 739-744
39. 39 Puett, D., Ryan, R.J. and Stevens, V.C. Circular dichroic and immunological properties of human chorionic gonadotropin-β carboxy terminal peptides. Int. J. Peptide Protein Res. 1982, 19, 506-513
40. 40 Rock, E.P., Czaplicki, J. and Milon, A. Structural analysis of the carboxyl terminal peptide from human chorionic gondadotropin beta-subunit by two-dimensional NMR spectroscopy. Am. J. reprod. Immun. 1996, 35, 156-162
41. 41 Louvet, J.P., Ross, G.T., Birken, S. and Canfield, R.E. Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J. clin. Endocrin. Metabolism 1974, 39, 1155-1158
42. 42 Berger, P., Kofler, R. and Wick, G. Monoclonal antibodies against human chorionic gonadotropin (hCG): II. Affinity and ability to neutralize the biological activity of hCG. Am. J. reprod. Immun. 1984, 5, 157-160
43. 43 Matzuk, M.M., Hsueh, A.J., Lapolt, P., Tsafriri, A., Keene, J.L. and Boime, I. The biological role of the carboxyl-terminal extension of human chorionic gonadotropin beta-subunit. Endocrinology 1990, 126, 376-383
44. 44 De Kretser, D.M., Atkins, R.C. and Paulsen, C.A. Role of the kidney in the metabolism of luteinizing hormone. J. Endocrin. 1973, 58, 425-434
45. 45 Sowers, J.R., Pekary, A.E., Hershman, J.M., Kanter, M. and DiStefano, J.J. Metabolism of exogenous human chorionic gonadotrophin in men. J. Endocrin. 1979, 80, 83-89
46. 46 Krishnan, T., Chandrashkar, S., Ghorpade, A.G. Approaches to recombinant hCG birth control vaccine. In: Recombinant and Synthetic Vaccines (Ed. Talwar G.P.). Narosa Publishing House, New Delhi, 1994, pp. 207-215